Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.24K | |||||||
| Operating revenue | ---- | ---- | --2.24K | ---- | ---- | ---- | ---- | ---- |
| Cost of revenue | ||||||||
| Gross profit | 2.24K | |||||||
| Operating expense | -85.40%1.01M | 100.48%6.93M | -66.29%3.45M | 518.67%10.25M | -1.79%1.66M | -56.85%1.69M | 351.63%3.91M | 865.55K |
| Selling and administrative expenses | -178.15%-1.04M | -24.62%1.33M | -71.69%1.76M | 375.01%6.22M | -19.40%1.31M | 53.27%1.63M | 27.37%1.06M | --832.38K |
| -Selling and marketing expense | -18.57%111.8K | 23.80%137.3K | 162.95%110.9K | 434.94%42.18K | --7.88K | ---- | ---- | ---- |
| -General and administrative expense | -196.56%-1.15M | -27.87%1.19M | -73.29%1.65M | 374.64%6.18M | -19.89%1.3M | 53.27%1.63M | 27.37%1.06M | --832.38K |
| Depreciation amortization depletion | -32.81%8.13K | 38.78%12.1K | -69.60%8.72K | -46.61%28.67K | 2.06%53.7K | 38.16%52.62K | 119.43%38.09K | --17.36K |
| -Depreciation and amortization | -32.81%8.13K | 38.78%12.1K | -69.60%8.72K | -46.61%28.67K | 2.06%53.7K | 38.16%52.62K | 119.43%38.09K | --17.36K |
| Other operating expenses | -63.47%2.04M | 231.55%5.59M | -57.86%1.68M | 1,264.45%4M | 3,169.84%293.01K | -99.68%8.96K | 17,677.12%2.81M | --15.81K |
| Operating profit | 85.40%-1.01M | -100.61%-6.93M | 66.31%-3.45M | -518.67%-10.25M | 1.79%-1.66M | 56.85%-1.69M | -351.63%-3.91M | -865.55K |
| Net non-operating interest income (expenses) | -6.85%16.4K | -61.91%17.61K | -5.72%46.23K | 25,504.15%49.03K | 92.28%-193 | -136.46%-2.5K | -84.84%6.86K | 45.23K |
| Non-operating interest income | -27.51%17.13K | -48.89%23.63K | 21,705.19%46.23K | -91.53%212 | 98.57%2.5K | -83.45%1.26K | -86.89%7.61K | --58.05K |
| Non-operating interest expense | -88.00%722 | --6.02K | ---- | -1,911.43%-48.82K | -28.32%2.7K | 398.01%3.76K | -94.11%755 | --12.82K |
| Other net income (expenses) | 1,910.27%484.03K | -105.13%-26.74K | 521.1K | -19.90%22.5K | -38.74%28.09K | 100.70%45.85K | -6.57M | |
| Special income (charges) | ---- | --15.95K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | --15.95K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 1,879.05%488.56K | -105.27%-27.46K | --521.1K | ---- | -19.90%22.5K | -38.74%28.09K | 100.70%45.85K | ---6.57M |
| Income before tax | 92.63%-510.85K | -140.37%-6.93M | 71.71%-2.89M | -524.12%-10.2M | 1.62%-1.63M | 56.93%-1.66M | 47.80%-3.86M | -7.39M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||
| Net income | 92.63%-510.85K | -140.37%-6.93M | 71.71%-2.89M | -524.12%-10.2M | 1.62%-1.63M | 56.93%-1.66M | 47.80%-3.86M | -7.39M |
| Net income continuous operations | 92.63%-510.85K | -140.37%-6.93M | 71.71%-2.89M | -524.12%-10.2M | 1.62%-1.63M | 56.93%-1.66M | 47.80%-3.86M | ---7.39M |
| Noncontrolling interests | ||||||||
| Net income attributable to the company | 92.63%-510.85K | -140.37%-6.93M | 71.71%-2.89M | -524.12%-10.2M | 1.62%-1.63M | 56.93%-1.66M | 47.80%-3.86M | -7.39M |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | ||||||||
| Net income attributable to common stockholders | 92.63%-510.85K | -140.37%-6.93M | 71.71%-2.89M | -524.12%-10.2M | 1.62%-1.63M | 56.93%-1.66M | 47.80%-3.86M | -7.39M |
| Diluted earnings per share | 95.71%-0.0003 | -112.12%-0.007 | 84.43%-0.0033 | -457.16%-0.0212 | 50.60%-0.0038 | 78.06%-0.0077 | 59.07%-0.0351 | -0.0858 |
| Basic earnings per share | 95.71%-0.0003 | -112.12%-0.007 | 84.43%-0.0033 | -457.16%-0.0212 | 50.60%-0.0038 | 78.06%-0.0077 | 59.07%-0.0351 | -0.0858 |
| Dividend per share | ||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |